Dr. Raymond currently serves as Director, Science and Regulatory Policy at Astellas. Prior to joining Astellas, Dr. Raymond served as a Director, Science and Regulatory Advocacy at PhRMA. In this role he focused on regulatory policy and advocacy issues including combination products, digital health, drug development tools, preclinical development, and model-informed drug development. Prior to PhRMA, he held a Health Program Specialist position with the National Institute of Neurological Disorders and Stroke at NIH where he coordinated efforts for the White House BRAIN Initiative, including developing the BRAIN Initiative Public-Private Partnership Program that brought together stakeholders from academia, industry, NIH, and FDA.